Top suggestions for id:944FF14B26664366D2ED944FF14B26664366D2ED |
- Length
- Date
- Resolution
- Source
- Price
- Clear filters
- SafeSearch:
- Moderate
- Hydro
- Ret
基因 - Selpercatinib
- Sevabertinib
PDUFA - Chinampa
- NMPA
- 吡咯替尼
艾瑞妮 - Esmos 2025
Berlín - Esmo
Sevabertinib - Retevmo
Selpercatinib - Zongertinib
- Herceptin
靶向 Her2 - Zongertinib
Hernexeos - Taletrectinib
- Capivasertib
- Sacituzumab
Tirumotecan - Herceptin 靶向
Her2 的信号 - 新药靶点发现与验证
- 2025 Esmo Asian Rc48
PD-1 RT Her2 Utuc - 细胞治疗
- Retevmo
- Onclive SGN
B6A Asco - Kras
Mutation - Oncomine DX
Target Test - Targeted Anti Tumor
Therapy - Kras
Pathway - Trastuzumab
Deruxtecan - Qupath
NSCLC - Esmo
- Herceptin
抑制 Her2
